Delivery Order SPE2DB22D2218-SPE2DB24FR2WW
Award Date
7/15/24
Potential Completion Date
8/5/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a $6,658.73 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of May 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $13,317.44 firm fixed-price delivery order is for the supply of the drug ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 200 mg vials of the pharmaceutical product ANDEXXA, with a ceiling value of $6,658.73. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a Delivery Order contract type with a Firm Fixed Price pricing mechanism. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $16,783.10 and was awarded by the Medical Supply Chain, a component of the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANDEXXA 200 MG VIALS. The contract has a ceiling value of $26,016.45 and an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,777.72, is for the delivery of the drug ANDEXXA 200 MG VIALS. It is a firm fixed-price contract with a completion date of December 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,658.73 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA). The $16,783.10 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for ANDEXXA 200 MG VIALS. The $20,794.59 firm fixed price contract has a completion date of July 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,344.30 firm fixed-price contract is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, with a completion date of July 17, 2025. This contract is not set aside and was awarded on an open competitive basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...